Natus Medical Inc
NTUS
NTUS was delisted on the 20th of July, 2022.
170 hedge funds and large institutions have $819M invested in Natus Medical Inc in 2021 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 57 increasing their positions, 55 reducing their positions, and 14 closing their positions.
138% more call options, than puts
Call options by funds: $1.89M | Put options by funds: $793K
100% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 14
9% more funds holding
Funds holding: 156 → 170 (+14)
4% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 55
0% less capital invested
Capital invested by funds: $819M → $819M (-$262K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tributary Capital Management
Omaha,
Nebraska
|
+$11.1M |
| 2 |
JP Morgan Chase
New York
|
+$7.42M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$6.86M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$5.64M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$10.7M |
| 2 |
Nuveen
Charlotte,
North Carolina
|
-$8.18M |
| 3 |
FAM
Fenimore Asset Management
Cobleskill,
New York
|
-$6.55M |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$6.28M |
| 5 |
SCM
Sio Capital Management
New York
|
-$4.34M |
NTUS Hedge Fund Activity: Q2 2021 in Review
170 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q2 2021, worth a combined $819M — down 0.03% from $819M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new NTUS positions and 14 closed out — a net gain of 14 holders — while 57 added to existing stakes and 55 trimmed.
The largest buyer was Tributary Capital Management, opening a new position worth an estimated $11.1M. The largest seller was Invesco, cutting an estimated $10.7M.
- 170 institutional investors held Natus Medical Inc (NTUS) as of Q2 2021, up from 156 in Q1 2021.
- Funds reported $819M of Natus Medical Inc stock for Q2 2021, down 0.03% quarter-over-quarter.
- 28 funds opened new Natus Medical Inc positions in Q2 2021 and 14 closed out, a net change of +14 holders.
- The largest Natus Medical Inc buyer in Q2 2021 was Tributary Capital Management, an estimated $11.1M added.
- The largest Natus Medical Inc seller in Q2 2021 was Invesco, an estimated $10.7M sold.
Based on aggregated 13F filings for Q2 2021.